Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05170295 · ClinicalTrials.gov registry record
Noninvasive Monitoring of Cerebral Blood Flow Autoregulation
A clinical trial, sponsored by Ochsner Health System.
- Completed
- Registry status
- 14
- Enrollment target
NCT05170295 is a clinical trial that has completed, run by Ochsner Health System. The registered enrollment target is 14 participants.
The verdict
NCT05170295 has completed, sponsored by Ochsner Health System.
- COMPLETED
- Registry status
- 14 participants
- Enrollment target
Study Summary
Rheoencephalography (REG) shows promise as a method for noninvasive neuromonitoring, because it reflects cerebrovascular reactivity. This protocol will study clinical and technical conditions required to use REG. Additionally, our goal is to study noninvasive peripheral bioimpedance pulse waveforms in order to substitute invasive SAP. A previous study demonstrated that REG can be used to detect spreading depolarization (SD), the early sign of brain metabolic disturbance. SD can be measured invasively with DC EEG amplifiers only. Our goal is to create an automatic notification function for REG monitoring indicating change of clinical conditions.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 14 participants |
| Start Date | 2018-04-18 |
| Est. Completion | 2021-04-28 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05170295
The ClinicalTrials.gov registry entry for NCT05170295 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 14 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Ochsner Health System, which has 29 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT05170295 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05170295 about?
NCT05170295 is a clinical study titled "Noninvasive Monitoring of Cerebral Blood Flow Autoregulation". Rheoencephalography (REG) shows promise as a method for noninvasive neuromonitoring, because it reflects cerebrovascular reactivity. This protocol will study clinical and technical conditions required to use REG. Additionally, our goal is to study noninvasive peripheral bioimpedance pulse waveforms ...
What is the current status of trial NCT05170295?
This trial is currently completed. The enrollment target is 14 participants. The study started on 2018-04-18. Estimated completion is 2021-04-28.
Who is sponsoring clinical trial NCT05170295?
This trial is sponsored by Ochsner Health System, which has 29 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.